GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹2,580 Cr | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr | ₹2,238 Cr |
What is the latest Trade Payables ratio of GLENMARK PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹2,580 Cr |
| Mar2024 | ₹2,536 Cr |
| Mar2023 | ₹2,000 Cr |
| Mar2022 | ₹2,289 Cr |
| Mar2021 | ₹2,238 Cr |
How is Trade Payables of GLENMARK PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,580 Cr | 1.72 | |
| Mar2024 | ₹2,536 Cr | 26.77 | |
| Mar2023 | ₹2,000 Cr | -12.59 | |
| Mar2022 | ₹2,289 Cr | 2.27 | |
| Mar2021 | ₹2,238 Cr | - | |
Compare Trade Payables of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,893.5 Cr | -1.4% | 1.1% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.4% |
1.1% |
-0.2% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses